Last Updated: June 24, 2026

Claims for Patent: 12,564,565

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 12,564,565

Title:	Stable pharmaceutical formulations of amino acids, peptides or proteins
Abstract:	The present disclosure relates to pharmaceutical formulations comprising an active ingredient belonging to the amino acid, peptide or protein classes and glycerin as excipient, characterized in that the glycerin has an iron content ≤0.2 ppm and an aldehyde and/or ketone species content ≤5 ppm.
Inventor(s):	Tiziano Fossati, Alessandro Di Maria
Assignee:	IBSA Institut Biochimique SA
Application Number:	US19/209,056
Patent Claims:	1. A stable pharmaceutical composition comprising: an active ingredient that is L-thyroxine (T4); and glycerin having: ≤0.2 ppm iron, and ≤5 ppm aldehyde and/or ketone species; wherein the glycerin is of vegetable origin. 2. The pharmaceutical composition of claim 1, wherein the pharmaceutical composition further comprises water. 3. The pharmaceutical composition of claim 1, wherein the pharmaceutical composition is an oral solution. 4. The pharmaceutical composition of claim 3, wherein the glycerin is comprised in a glycerin-water mixture. 5. The pharmaceutical composition of claim 1, wherein the pharmaceutical composition is in form of a soft capsule. 6. The pharmaceutical composition of claim 1, wherein the glycerin is comprised in a glycerin-water mixture. 7. The pharmaceutical composition of claim 1, wherein the aldehyde and/or ketone species is 2,4-dinitrophenylhydrazine (DNPH)-reactive. 8. A process for the preparation of a stable pharmaceutical composition, the process comprising: combining an active ingredient that is L-thyroxine (T4) with glycerin having: ≤0.2 ppm iron, and ≤5 ppm aldehyde and/or ketone species, wherein the glycerin is of vegetable origin. 9. The process of claim 8, wherein the glycerin is comprised in a glycerin-water mixture. 10. The process of claim 8, further comprising quantitating the iron content in the glycerin to determine whether the iron content is ≤0.2 ppm. 11. The process of claim 8, further comprising quantitating the aldehyde and/or ketone species content in the glycerin to determine whether the aldehyde and/or ketone species content is ≤5 ppm.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.